PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-4.35%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$264M
AUM Growth
+$264M
(-19%)
Cap. Flow
-$33.5M
Cap. Flow
% of AUM
-12.65%
Top 10 Holdings %
Top 10 Hldgs %
53.84%
Holding
118
New
19
Increased
18
Reduced
12
Closed
28
Top Buys
| 1 |
Grifois
GRFS
|
$9.94M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
$6.11M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$5.55M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.14M |
| 5 |
Establishment Labs
ESTA
|
$4.83M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$10.1M |
| 2 |
Danaher
DHR
|
$7.15M |
| 3 |
ARQL
Arqule Inc
ARQL
|
$6.98M |
| 4 |
Guardant Health
GH
|
$6.04M |
| 5 |
Zimmer Biomet
ZBH
|
$5.84M |
Sector Composition
| 1 | Healthcare | 87.98% |
| 2 | Industrials | 2.56% |
| 3 | Consumer Staples | 1.56% |
| 4 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Inspire Medical Systems
INSP
$2.77B
| $21.8M | 3.73% | 357,700 -42,300 | -11% | -$2.58M |
|
|
NSTG
2
DELISTED
NanoString Technologies, Inc.
NSTG
| $18.9M | 3.22% | 873,800 +152,885 | +21% | +$3.3M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $16.1M | 2.75% | 117,442 -42,558 | -27% | -$5.84M |
|
4
ICU Medical
ICUI
$3.15B
| $14.8M | 2.52% | 92,500 +13,381 | +17% | +$2.14M |
|
|
5
Establishment Labs
ESTA
$1.2B
| $14.1M | 2.41% | 745,163 +255,673 | +52% | +$4.83M |
|
6
STAAR Surgical
STAA
$1.36B
| $13M | 2.22% | 504,012 -34,588 | -6% | -$892K |
|
|
XENT
7
DELISTED
Intersect ENT, Inc
XENT
| $11.4M | 1.95% | 670,000 +359,174 | +116% | +$6.11M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $11.3M | 1.93% | 67,109 +20,000 | +42% | +$3.37M |
|
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $11.1M | 1.9% | 40,000 +20,000 | +100% | +$5.55M |
|
|
10
Grifois
GRFS
$6.78B
| $9.94M | 1.7% | +496,201 | New | +$9.94M |
|
11
Gilead Sciences
GILD
$140B
| $9.51M | 1.62% | 150,000 +50,000 | +50% | +$3.17M |
|
12
Smith & Nephew
SNN
$16.3B
| $8.66M | 1.48% | 180,000 -70,000 | -28% | -$3.37M |
|
|
RCM
13
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.76M | 1.16% | 757,139 +109,998 | +17% | +$982K |
|
14
DexCom
DXCM
$29.5B
| $6.72M | 1.15% | 45,000 -17,287 | -28% | -$2.58M |
|
|
IVC
15
DELISTED
Invacare Corporation
IVC
| $6.15M | 1.05% | 819,874 -109,702 | -12% | -$823K |
|
16
OrthoPediatrics
KIDS
$536M
| $6.08M | 1.04% | 172,500 +28,092 | +19% | +$990K |
|
17
Baxter International
BAX
$12.7B
| $5.25M | 0.9% | 60,000 +22,500 | +60% | +$1.97M |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.14M | 0.88% | +52,500 | New | +$5.14M |
|
19
CONMED
CNMD
$1.68B
| $4.57M | 0.78% | 47,500 -2,500 | -5% | -$240K |
|
20
10x Genomics
TXG
$1.74B
| $4.54M | 0.77% | +90,000 | New | +$4.54M |
|
|
QTNT
21
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $4.39M | 0.75% | 565,094 +346,418 | +158% | +$2.69M |
|
22
Greenlane Holdings
GNLN
$4.71M
| $4.13M | 0.71% | 1,217,890 +752,892 | +162% | +$2.55M |
|
|
GWPH
23
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.45M | 0.59% | +30,000 | New | +$3.45M |
|
24
United Therapeutics
UTHR
$13.8B
| $3.11M | 0.53% | 39,000 | – | – |
|
25
Masimo
MASI
$7.59B
| $2.99M | 0.51% | 20,099 -17,401 | -46% | -$2.59M |
|